Congress urges Biden to act on baby formula shortage
ABC News’ National Policy reporter Anne Flaherty reports on the FDA’s latest efforts to get baby formula back on shelves, as well as the latest on the investigation into Abbott’s tax practices. WATCH the ABC News Livestream: https://bit.ly/3rzBHum SUBSCRIBE to…
Read More »
FDA authorizes COVID-19 booster for children ages 5 to 11
ABC News contributor and epidemiologist Dr. John Brownstein discusses COVID-19 booster shots for young kids and the potential risks. WATCH the ABC News Livestream: https://bit.ly/3rzBHum SUBSCRIBE to ABC News: https://bit.ly/2vZb6yP WATCH MORE on http://abcnews.go.com/ LIKE ABC News on FACEBOOK: https://www.facebook.com/abcnews…
Read More »
ABC News Live: Biden meets with families of victims in supermarket shooting
Plus, officials investigate the California church shooting as a hate crime, and the FDA and Abbott agree to reopen Abbott’s plant in Michigan to help ease baby formula shortage.
Read More »
FDA commissioner gives update on baby formula shortage l GMA
Dr. Robert Califf details the steps the U.S. Food and Drug Administration is taking to improve the critical supply of formula available for families. READ MORE: https://gma.abc/3FT5nun #ABCNews #BabyFormula #FDA
Read More »
Baby formula shortage worsens
The FDA is looking at ways to import more baby formula to help ease the nationwide shortage. ABC News’ Mona Kosar Abdi reports.
Read More »
FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk
ABC News medical contributor Dr. Alok Patel breaks down the news over the Johnson & Johnson COVID-19 vaccine’s rare risk of blood clots and what it means for people who already received the shot. WATCH the ABC News Live Stream…
Read More »
FDA limits use of J&J COVID vaccines
Following an investigation into reports of rare blood clots, the FDA is restricting access to the vaccine. READ MORE: https://abcn.ws/3P3ch4l #ABCNews #Vaccine #COVID19 #BloodClot
Read More »
FDA permits marketing of diagnostic test for Alzheimer’s disease
The FDA permitted marketing for the first in vitro diagnostic test for early detection of symptoms associated with Alzheimer’s disease, which is aimed at eliminating the need for expensive PET scans.
Read More »